Acapella^® Choice Blue PEP Therapy Device

Sold per Each

The Acapella^® choice blue vibratory PEP device is for single patient use and provides positive expiratory pressure (PEP) therapy for patients who have Cystic Fibrosis, COPD, asthma, and lung diseases with secretory problems, and patients with atelectasis.

Acapella^® devices require 15-20 minutes of therapy time versus 20-40 minutes for traditional chest physiotherapy2. It may also be used simultaneously with nebulized aerosol drug delivery.

Features:

• Functional in any position – Trendelenberg, standing, or sitting
• Adjustable frequency and flow resistance settings
• Treatment can be performed in less than half the time of a conventional CPT session
• Proximal medication nebulizer placement on the Acapella® delivers equivalent aerosol to the lung compared to use of nebulizer alone
• Disassembly for easy cleaning and disinfection
• > 15 L/min expiratory flow requirement
• Enhanced dial markings for easy resistance setting changes
• Aids in mobilization of retained secretions
• Prevents or reverses atelectasis
• Reduces air trapping
• Optimizes delivery of bronchodilators

References:

1. Positive expiratory pressure – Common clinical applications and physiological effects. Fagevik Olsén, Monika et al. Respiratory Medicine , Volume 109 , Issue 3 , 297 - 307.
2. Cystic Fibrosis Foundation. Chest Physical Therapy. www.cff.org/life-with-CF/Treatments-and-Therapies/Airway-Clearance/Chest-Physical-Therapy. Pages 1-12.
3. Scintigraphic assessment of radio-aerosol pulmonary deposition with the acapella positive expiratory pressure device and various nebulizer configurations. Mesquita F.O.S., Galindo-Filho V.C., Neto J.L.F., Galvao A.M., Brandao S.C.S., Fink J.B., Dornelas-de-Andrade A. (2014) Respiratory Care, 59 (3) , pp. 328-333.

PRODUCT UPDATE  -  Acapella DH Green,  Acapella Choice Green and  Acapella Duet have all been replaced with the Acapella Choice Blue  (Item Code:  Smi278000)